Training and education

BSc medical sciences with haematology (first class) - Imperial College School of Medicine, 2003
MBBS (medical degree) - Imperial College School of Medicine, 2005
Member of the Royal College of Physicians - 2008
Fellow of the Royal College of Pathologists - 2013
Haematology specialist trainee - Wessex, 2009-2014

Experience

Dr Boyce is a consultant haematologist who joined the Trust in 2014. She is lead for haematology and blood transfusion for the Trust and lead for thrombotic thrombocytopenic purpura (TTP) for the Wessex region.

Dr Boyce’s specialist interests are in blood clotting and immune haematology disorders. She's a member of the UK Haemophilia Centres Doctor’s Organisation and contributes to their national guidelines. She has weekly specialist clinics for bleeding disorders and haemophilia, thrombosis, platelets disorders and TTP.

Research

Dr Boyce is primary investigator for trials researching haemophilia, platelet disorders and thrombosis.

Recent publications

Boyce S, Rangarajan S. RNAi for the Treatment of People with Hemophilia: Current Evidence and Patient Selection. J Blood Med. 2023 Apr 22;14:317-327.
Zwagemaker AF, Kloosterman FR, Gouw SC, Boyce S, Brons P, Cnossen MH, Collins PW, Eikenboom J, Hay C, Hengeveld RCC, Jackson S, Klopper-Tol CAM, Kruip MJHA, Gorkom BL, Male C, Nieuwenhuizen L, Shapiro S, Fijnvandraat K, Coppens M; DYNAMO study group. Little discrepancy between one-stage and chromogenic factor VIII (FVIII)/IX assays in a large international cohort of persons with nonsevere hemophilia A and B. J Thromb Haemost. 2023 Apr;21(4):850-861.
Chowdary P, Shapiro S, Makris M, Evans G, Boyce S, Talks K, Dolan G, Reiss U, Phillips M, Riddell A, Peralta MR, Quaye M, Patch DW, Tuddenham E, Dane A, Watissée M, Long A, Nathwani A. Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B. N Engl J Med. 2022 Jul 21;387(3):237-247.
Boyce S, James I, Rangarajan S, Curry N, Bagot C, Austin S, Laffan M, Mangles S, Chandrakumaran K, Mundy C. Seroprevalence to adeno-associated virus type 6 in people with hemophilia B from a UK adult cohort. Res Pract Thromb Haemost. 2022 Jun 3;6(4):e12705.
Zwagemaker AF, Kloosterman FR, Coppens M, Gouw SC, Boyce S, Bagot CN, Beckers EAM, Brons P, Castaman G, Eikenboom J, Jackson S, Kruip MJHA, Leebeek FWG, Meijer K, Nieuwenhuizen L, Pabinger I, Fijnvandraat K; DYNAMO Study Group. Desmopressin for bleeding in non-severe hemophilia A: Suboptimal use in a real-world setting. Res Pract Thromb Haemost. 2022 Aug 31;6(6):e12777.
Jacob C, Rani KA, Holton PJ, Boyce SR, Weir NU, Griffith CR, Eynon CA. Malignant middle cerebral artery syndrome with thrombotic thrombocytopenia following vaccination against SARS-CoV-2. J Intensive Care Soc. 2022 Nov;23(4):479-484.
Craven B, Lester W, Boyce S, Thomas W, Kanny A, Davies C, Pavord S, Hermans J, Makris M, Bart-Smith E, Arnott S, Hunt BJ, Chudakou P, Calvert A, Singh D, Scully M. Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis. Blood. 2022 Apr 21;139(16):2553-2560.

Contact details

You can contact Dr Boyce via her secretary, Fathiya El-Kindy, by calling 023 8120 8862.